Neutral Actions of Raltegravir on Adipogenesis, Glucose Metabolism and Lipolysis in 3T3-L1 Adipocytes
Journal:
Current HIV Research
Volume:
9
Page:
174-179
Author(s):
Patricia Perez-Matute, Laura Perez-Martinez, Jose R. Blanco and Jose A. Oteo
Antineoplastic Potential of Medicinal Plants
Journal:
Recent Patents on Biotechnology
Volume:
5
Page:
85-94
Author(s):
M. Shynu, K. P. Gupta and M. Saini
Bioengineering RNA Silencing Across the Life Kingdoms
Journal:
Recent Patents on Biotechnology
Volume:
5
Page:
118-146
Author(s):
R. Alvarez-Fernandez, S. Lopez-Gomollon, A. F. Lopez-Martinez and F. E. Nicolas
Applications of 211At and 223Ra in Targeted Alpha-Particle Radiotherapy
Journal:
Current Radiopharmaceuticals
Volume:
4
Page:
283-294
Author(s):
Ganesan Vaidyanathan and Michael R. Zalutsky
Targeted Alpha Therapy with 213Bi
Journal:
Current Radiopharmaceuticals
Volume:
4
Page:
295-305
Author(s):
Alfred Morgenstern, Frank Bruchertseifer and Christos Apostolidis
Toxicity and Relative Biological Effectiveness of Alpha Emitting Radioimmunoconjugates
Journal:
Current Radiopharmaceuticals
Volume:
4
Page:
321-328
Author(s):
Jostein Dahle, Nasir Abbas, Oyvind S. Bruland and Roy H. Larsen
Future Prospects for Targeted Alpha Therapy
Journal:
Current Radiopharmaceuticals
Volume:
4
Page:
336-342
Author(s):
Barry J. Allen
Whole Organism Based Techniques and Approaches in Early Stage Oncology Drug Discovery-Patents and Trends
Journal:
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume:
5
Page:
183-191
Author(s):
Richard J. Hampson and Michael D. Wyatt
Glycerophospholipid Synthesis as a Novel Drug Target Against Cancer
Journal:
Current Molecular Pharmacology
Volume:
4
Page:
167-175
Author(s):
Vincenza Dolce, Anna Rita Cappello, Rosamaria Lappano and Marcello Maggiolini
The Offer of Chemistry to Targeted Therapy in Cancer
Journal:
Recent Patents on Biotechnology
Volume:
5
Page:
174-182
Author(s):
Ikram Jemel, Karim Jellali, Jihene Elloumi and Sami Aifa